All Stories

  1. To thin, or not too thin: questions of anticoagulation for pulmonary hypertension
  2. The Pulmonary Hypertension Global Patient Survey: understanding the experiences and perspectives of patients
  3. Management after combined BPA and medical therapy in CTEPH: time for cardiopulmonary exercise testing
  4. Navigating between management of pulmonary arterial hypertension and cardiometabolic and pulmonary comorbidities
  5. Impact of preoperative body mass index on long-term survival, quality of life, and functional outcomes after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: Results from the UK National Cohort
  6. The global burden of pulmonary arterial hypertension: profound but improving?
  7. Worldwide CTEPH Registry: Long-Term Outcomes With Pulmonary Endarterectomy, Balloon Pulmonary Angioplasty, and Medical Therapy
  8. Efficacy and safety of selexipag in patients with inoperable or persistent/recurrent CTEPH (SELECT randomised trial)
  9. Pulmonary hypertension associated with lung diseases
  10. CTEPH is an uncommon complication of COVID-19: UK national surveillance and observational screening cohort studies
  11. Shared and Distinct Genomics of Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Embolism
  12. The Digital 1-Minute Walk Test: A New Patient-centered Cardiorespiratory Endpoint
  13. Pulmonary Embolism (PE) to Chronic Thromboembolic Pulmonary Disease (CTEPD): Findings from a Survey of UK Physicians
  14. Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension
  15. Chronic Thromboembolic Pulmonary Hypertension: A Review of the Multifaceted Pathobiology
  16. Oral Treprostinil is Associated with Improved Survival in FREEDOM-EV and its Open-Label Extension
  17. Predictors of outcomes in mild pulmonary hypertension according to 2022 ESC/ERS Guidelines: the EVIDENCE-PAH UK study
  18. Illuminating the many faces of pulmonary hypertension
  19. European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of Cardiology
  20. Angiopoietin 2 and hsCRP are associated with pulmonary hemodynamics and long-term mortality respectively in CTEPH—Results from a prospective discovery and validation biomarker study
  21. Corrigendum to: 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respir...
  22. Right ventricular–pulmonary artery coupling in chronic thromboembolic pulmonary hypertension
  23. First Genotype–Phenotype Study in TBX4 Syndrome: Gain-of-Function Mutations Causative for Lung Disease
  24. Conduction disease in IPAH: prevalence and clinical implications
  25. Prevalence and clinical significance of conduction disease in patients with idiopathic pulmonary arterial hypertension
  26. Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension
  27. Different Cytokine Patterns in BMPR2-Mutation-Positive Patients and Patients With Pulmonary Arterial Hypertension Without Mutations and Their Influence on Survival
  28. Prevalence and clinical impact of atrioventricular conduction disease in patients with idiopathic pulmonary arterial hypertension
  29. ERS statement on chronic thromboembolic pulmonary hypertension
  30. Plasma metabolomics in chronic thromboembolic pulmonary hypertension
  31. CAMPHOR score: patient-reported outcomes are improved by pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension
  32. The ADAMTS13–VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension
  33. Response by Cannon and Pepke-Zaba to Letter Regarding Article, “Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy: Results From the United Kingdom National Cohort”
  34. Long-Term Outcome of Patients With Chronic Thromboembolic Pulmonary Hypertension
  35. Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
  36. Chronic Thromboembolic Pulmonary Hypertension
  37. Pulmonary hypertension in patients with COPD: NO treatment?
  38. Endothelial dysfunction in vascular disease